Cambridge and Boston, MA. Wed. July 4, 2012 One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
New research by a team from the Broad Institute, Dana-Farber Cancer Institute, and Massachusetts General Hospital suggests that some of the answers to this question do not lie in cancer cells themselves. To find the answers, scientists are looking beyond tumor cells, studying the interplay between cancer cells and their healthy counterparts. The research team has found that normal cells that reside within the tumor, part of the tumor microenvironment, may supply factors that help cancer cells grow and survive despite the presence of anti-cancer drugs. These findings appear online this week in a paper published in Nature.
"Historically, researchers would go to great lengths to pluck out tumor cells from a sample and discard the rest of the tissue," said senior author Todd Golub director of the Broad's Cancer Program and Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute. Golub is also a professor at Harvard Medical School and an investigator at Howard Hughes Medical Institute. "But what we're finding now is that those non-tumor cells that make up the microenvironment may be an important source of drug resistance."
To investigate how the tumor microenvironment may contribute to drug resistance, the researchers designed experiments in which cancer cells were grown in the same wells (miniscule test tubes no larger than a pencil eraser) along with normal cells. These co-cultured cells were then treated with anti-cancer drugs. When grown alone, s
'/>"/>
| Contact: Haley Bridger hbridger@broadinstitute.org 617-714-7968 Broad Institute of MIT and Harvard Source:Eurekalert |
Related biology news :
1. Researchers identify need to sample multiple tumor zones in breast cancer
2. Cancerous tumors deliver pro-metastatic information in secreted vesicles
3. Clusters of cooperating tumor-suppressor genes are found in large regions deleted in common cancers
4. A single stem cell mutation triggers fibroid tumors
5. Immune-response genes affecting breast tumor eradication
6. TGen leads new National Institutes of Health study of brain tumors
7. Dental X-rays linked to common brain tumor
8. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
9. The loss of a protein makes jump the tumor to the lymph node
10. Sensitive test helps improve vaccine safety
11. Restoring streamside forests helps songbirds survive the winter in Californias Central Valley
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |